Drug Integrity

Drug and Device Recalls

Policy 0009

02/01/2000 Introduced
02/01/2005 Revised
11/01/2009 Reapproved

AMCP supports the use of technologies to enhance communication of recall information to all relevant parties including patients who may have received such products.

Prescription Drug Importation

Policy 0302

02/01/2003 Introduced

02/01/2008 Revised

02/01/2013 Revised

02/21/2021 Revised

Legislation or regulation that would permit the importation of prescription drugs presents potential patient safety issues. Allowing the importation of prescription drugs raises a challenge to ensure that quality assurance standards and supply chain integrity are maintained. There is scant evidence that importation will meaningfully impact the price of prescription drugs available to U.S. consumers, but ample evidence that it presents a clear threat to the security of our nation’s drug supply. AMCP will oppose legislation or regulation that would allow the importation of prescription drugs for sale in the United States until more conclusive data are available as to its likely impact.

(See also AMCP Managed Care Pharmacy Practice Positions - Prescription Drug Importation)